English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Polyclonal and monoclonal anti-tissue plasminogen activator (t-PA) antibodies were characterized by using enzyme immunoassay (EIA) in which β-D-galactosidase was coupled to anti-t-PA antibody (Fab'). 2:2 B10 and 1:3 G5 antibodies, specific for both one-chain and two-chain t-PA, strongly bound with one-chain t-PA purified from cultured melanoma cell lines, but 1:3 C5 antibody bound weakly with such t-PA. When polyclonal t-PA antibody was used as the first reaction antibody immobilized on silicone pieces, anti-t-PA polyclonal antibody mainly reacted with 2:2 B10 or 1:3 C5 antigenic determinant. When t-PA levels in the plasma were determined, the presence of EDTA enhanced the sensitivity of t-PA determination by the present EIA technic. 2:2 B10 monoclonal antibody detected a part of t-PA molecules in the plasma that polyclonal antibody detected. T-PA was mainly detected in the endothelial cells, but not in the muscular layer of inferior mesenteric artery when immunochemical technic was used where polyclonal t-PA antibody was applied.

Characterization of various antibodies against tissue plasminogen activator using highly sensitive immunoassay.